Several lines of study have recently demonstrated that an increased level of soluble IL-7R (sIL-7R) had clinical implications in autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS), and SLE [26, 31–33]. Here, IL7R is linked to autoimmune disease.